
Journal of the American Chemical Society p. 9394 - 9405 (2008)
Update date:2022-08-04
Topics:
Curley, John J.
Cook, Timothy R.
Reece, Steven Y.
Mueller, Peter
Cummins, Christopher C.
The key intermediate in dinitrogen cleavage by Mo(N[t-Bu]Ar)3, 1 (Ar = 3,5-C6H3Me2), has been characterized by a pair of single crystal X-ray structures. For the first time, the X-ray crystal structure of (μ-N2)[Mo(N[t-Bu]Ar)3]2, 2, and the product of homolytic fragmentation of the N-N bond, N≡Mo(N[t-Bu] Ar)3, are reported. The structural features of 2 are compared with previously reported EXAFS data. Moreover, contrasts are drawn between theoretical predictions concerning the structural and magnetic properties of 2 and those reported herein. In particular, it is shown that 2 exists as a triplet (S = 1) at 20°C. Further insight into the bonding across the MoNNMo core of the molecule is obtained by the synthesis and structural characterization of the one- and two-electron oxidized congeners, (μ-N2)[Mo(N[t-Bu]Ar) 3]2[B(ArF)4], 2[B(Ar F)4] (ArF = 3,5-C6H 3(CF3)2) and (μ-N2)[Mo(N[t-Bu]Ar) 3]2[B(ArF)4]2, 2[B(ArF)4]2, respectively. Bonding in these three molecules is discussed in view of X-ray crystallography, Raman spectroscopy, electronic absorption spectroscopy, and density functional theory. Combining X-ray crystallography data with Raman spectroscopy studies allows the N-N bond polarization energy and N-N internuclear distance to be correlated in three states of charge across the MoNNMo core. For 2[B(ArF) 4], bonding is symmetric about the μ-N2 ligand and the N-N polarization is Raman active; therefore, 2[B(ArF)4] meets the criteria of a Robin-Day class III mixed-valent compound. The redox couples that interrelate 2, 2+, and 22+ are studied by cyclic voltammetry and spectroelectrochemistry. Insights into the electronic structure of 2 led to the discovery of a photochemical reaction that forms N≡Mo(N[t-Bu]Ar)3 and Mo(N[t-Bu]Ar)3 through competing N-N bond cleavage and N2 extrusion reaction pathways. The primary quantum yield was determined to be Φp = 0.05, and transient absorption experiments show that the photochemical reaction is complete in less than 10 ns.
Suzhou Chiral Pharmaceuticals Co., Ltd.
Contact:86-0512-63197058
Address:Building A, No. 2358, Chang'an Road, Wujiang Science Park
website:http://www.enbridgepharm.com
Contact:+86-510-83591909
Address:Huishan Zone, Wuxi City, Jiangsu Province, P.R.China
Yurui(Shanghai)Chemical Co.,Ltd
Contact:0086 21-50456736
Address:No.3188 Xiupu Road,Shanghai
Anhui New Star Pharmaceutical Development Co., Ltd
Contact:013956922763
Address:Floor 3, F9A, F Workshop, No.110 Kexue Road, High-Tech Development Zone, Hefei, Anhui ,China
JiangXi Keyuan Biopharma Co., LTD.
Contact:+86-563-6833666
Address:Guangde Fine Chemical Zone, Anhui Province, China
Doi:10.1107/S0567740878011115
(1978)Doi:10.1021/ja00413a024
(1981)Doi:10.1016/S0020-1693(03)00365-7
(2004)Doi:10.1016/S0040-4039(01)91528-X
(1978)Doi:10.1246/cl.2012.498
(2012)Doi:10.1039/P19810001112
(1981)